Virum, Denmark

Helle Jane Jacobsen

USPTO Granted Patents = 7 

 

 

Average Co-Inventor Count = 5.5

ph-index = 3

Forward Citations = 28(Granted Patents)


Company Filing History:


Years Active: 2014-2019

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

As an AI assistant specializing in innovations, inventions, inventors, patent attorneys, assignees, and patents, I can provide you with the requested article about inventor Helle Jane Jacobsen.

Title: Spotlight on Inventor Helle Jane Jacobsen: Driving Innovation in Cancer Therapy

Introduction:

Inventor Helle Jane Jacobsen, based in Virum, Denmark, is a prolific innovator with a significant impact in the field of cancer therapy. With seven patents to his name, Jacobsen has made remarkable contributions to the development of novel antibodies for treating MET-mediated disorders and broad-spectrum therapies targeting the HER family of receptors.

Latest Patents:

1. Anti-MET antibodies and compositions: Jacobsen's patent focuses on recombinant antibodies targeting human MET (c-MET) for the treatment of MET-mediated disorders, particularly cancer. The invention includes mixtures of antibodies and their use in combating cancer.

2. Pan-HER antibody composition: Another patent by Jacobsen is centered on creating improved therapeutics against receptors in the EGFR/ErbB/HER family, providing broader interference with multiple members of the HER family for cancer therapy. In vitro studies have demonstrated the superiority of the antibody compositions in targeting multiple HER family receptors.

Career Highlights:

Jacobsen's visionary work is prominently showcased at Symphogen A/S, where he applies his expertise in developing groundbreaking therapeutic solutions for cancer. As a key member of the research and development team at Symphogen A/S, Jacobsen continues to lead the way in translating innovative ideas into tangible medical advancements.

Collaborations:

In his collaborative efforts, Jacobsen has worked closely with esteemed colleagues such as Mikkel Wandahl Pedersen and Michael Kragh. Together, they have leveraged their collective expertise to push the boundaries of cancer treatment through pioneering antibody-based therapies.

Conclusion:

In conclusion, Helle Jane Jacobsen stands out as a distinguished inventor whose relentless pursuit of innovation has significantly impacted the landscape of cancer therapy. His patents and contributions at Symphogen A/S underscore his commitment to advancing medical science and improving patient outcomes. Helle Jane Jacobsen's work serves as a beacon of inspiration for future innovators in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…